No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents, Immunological / adverse effects
-
Antineoplastic Agents, Immunological / therapeutic use
-
Female
-
Gastric Mucosa* / drug effects
-
Gastric Mucosa* / injuries
-
Gastric Mucosa* / pathology
-
Gastric Mucosa* / physiology
-
Gastritis* / chemically induced
-
Gastritis* / complications
-
Gastritis* / therapy
-
Humans
-
Immune Checkpoint Inhibitors / adverse effects*
-
Immune Checkpoint Inhibitors / therapeutic use
-
Middle Aged
-
Ovarian Neoplasms / drug therapy*
-
Phthalazines / adverse effects
-
Phthalazines / therapeutic use
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Regeneration
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Immune Checkpoint Inhibitors
-
Phthalazines
-
Piperazines
-
pembrolizumab
-
olaparib